Lucy Scientific Discovery Inc. (LSDI)

Lucy Scientific Discovery will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
2,000,000
Deal Size
$8.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap 64.23M
Revenue (ttm) n/a
Net Income (ttm) -5.94M
Shares Out 16.06M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About LSDI

Lucy Scientific Discovery is an early-stage psychotropics contract manufacturing company focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. In August 2021, Health Canada’s Office of Controlled Substances granted us a Controlled Drugs and Substances Dealer’s Licence. The Dealer’s Licence authorizes us to develop and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in contr... [Read more]

Industry Health Care
Founded 2017
Country Canada
Stock Exchange NASDAQ
Ticker Symbol LSDI
Full Company Profile

Financial Performance

Financial Statements

News

Lucy Scientific Discovery IPO Registration Document (S-1)

Lucy Scientific Discovery has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC